Nautilus Biotechnology

Developer of proteomics platform for drug development

placeSeattle, Washington, United States calendar_todayFounded 2016 groups134 employees language nautilus.bio

Registered entities

Social engagement

Social engagement: 13.8K social following, 9 posts in the last 12 months — below the industry typical range.

Investor mix

10 investors on record; lead investors include Vulcan; 1 has since exited.

Investor typeCountShare
Venture capital880%
Other / undisclosed220%

Hiring activity

Hires occasionally

1 role tracked across 1 of the last 12 months

23 Oct 2025 · Director, IT · Seattle

12 Sep 2025 · Senior HR Business Partner · San Carlos

7 Sep 2025 · Director, Operations · San Carlos

13 Aug 2025 · Senior Software Engineer · San Carlos

Based on job postings tracked across public sources.

Recent activity

2 Jul 2026
Product launch
Nautilus VoyagerTM Platform
1 Jul 2026
Event
Nautilus VoyagerTM Platform webinar
29 Jun 2026
Event
AAIC2026
Coming soon